Genetic polymorphisms predicting the outcome of bone marrow transplants

British Journal of Haematology

Volumn 127, Issue 5, 2004, Pages 479-490

  Dickinson, Anne M ^a   Middleton, Peter G ^a   Rocha, Vanderson ^b   Gluckman, Eliane ^b   Holler, Ernst ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Gene polymorphisms; Haematopoietic stem cell transplants

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLOPHOSPHAMIDE; CYTOCHROME P450 2B6; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MANNOSE BINDING LECTIN; METHOTREXATE; MYELOPEROXIDASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BONE MARROW TRANSPLANTATION; CROHN DISEASE; DRUG METABOLISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HLA MATCHING; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MUCOSA INFLAMMATION; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

BONE MARROW TRANSPLANTATION; CYTOKINES; DONOR SELECTION; GENES, MHC CLASS II; GRAFT VS HOST DISEASE; HUMANS; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME;

EID: 10344261473     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05216.x     Document Type: Review

References (55)

1. Bogunia-Kubik, K., Polak, M. & Lange, A. (2003) TNF polymorphisms are associated with toxic but not with aGvHD complications in the recipients of allogeneic sibling haematopoietic stem cell transplantation. Bone Marrow Transplantation, 32, 617-622.
2. Brok, H.P., Vossen, J.M. & Heidt, P.J. (1998) IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells. Bone Marrow Transplantation 22, 1005-1010.
3. de Bueger, M., Bakker, A., van Rood, J.J., Van Der Woude, F. & Goulmy, E. (1992) Tissue distribution of human minor histocompatibility antigens (Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.). Journal of Immunology, 149, 1788-1794.
4. Cavet, J., Middleton, P.G., Segall, M., Noreen, H., Davies, S.M. & Dickinson, A.M. (1999) Recipient tumour necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA matched sibling bone marrow transplants. Blood, 94, 3941-3946.
5. Cavet, J., Dickinson, A.M., Norden, J., Taylor, P.R.A., Jackson, G.H. & Middleton, P.G. (2001) Interferon-gamma and interleukin-six gene polymorphisms associate with graft versus host disease in HLA-matched sibling bone marrow transplantation. Blood, 98, 1594-1600.
6. Collins, R.W.M. (2004) Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. European Journal of Immunogenetics, 31, 105-114.
7. Cullup, H., Dickinson, A.M., Jackson, G.H., Taylor, P.R.A., Cavet, J. & Middleton, P.G. (2001) Donor interleukin-1 receptor antagonist genotype associated with acute graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic transplants. British Journal of Haematology, 113, 807-813.
8. Cullup, H., Dickinson, A.M., Cavet, J., Jackson, G.H. & Middleton, P.G. (2003) Polymorphisms of IL-1alpha constitute independent risk factors for chronic graft versus host disease following allogeneic bone marrow transplantation. British Journal of Haematology, 122, 778-787.
9. Dickinson, A.M., Cavet, J., Cullup, H., Wang, X.N., Sviland, L. & Middleton, P.G. (2001) GvHD risk assessment in hematopoietic stem cell transplantation: Role of cytokine gene polymorphisms and an in vitro human skin explant model. Human Immunology, 62, 1266-1276.
10. Evans, W.E. (2002) Differing effects of methylenetetrahydrofolate reductase single nucleotide polymorphisms on methotrexate efficacy and toxicity in rheumatoid arthritis. Pharmacogenetics, 12, 181-182.
11. Fishman, D., Faulds, G., Jeffry, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S. & Woo, P. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. Journal of Clinical Investigation, 102, 1369-1376.
12. Giebel, S., Locatelli, F., Lamparelli, T., Velardi, A., Davies, S., Frumento, G., Maccario, R., Bonetti, F., Wojnar, J., Martinetti, M., Frassoni, F., Giorgiani, G., Bacigalupo, A. & Holowiecki, J. (2003) Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood, 102, 814-819.
13. Goulmy, E. (1996) Human minor histocompatibility antigens. Current Opinion in Immunology, 8, 75-81.
14. Goulmy, E., Termijtelen, A., Bradley, B.A. & van Rood, J.J. (1977) Y-antigen killing by T cells of women is restricted by HLA. Nature, 266, 544-545.
15. Goulmy, E., Blokland, E., van Rood, J., Charmot, D., Malissen, B. & Mawas, C (1980) Production, expansion and clonal analysis of T cells with specific HLA-restricted male lysis. Journal of Experimental Medicine, 152, 182s-190s.
16. Goulmy, E., Gratama, J.W., Blokland, E., Zwaan, F.E., van Rood, J.J. (1983) A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft versus host disease. Nature, 302, 159-161.
17. Grainger, D.J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P.R., Metcalfe, J.C., Carter, N.D. & Spector, T.D. (1999) Genetic control of the circulating concentration of transforming growth factor type beta 1. Human Molecular Genetics, 8, 93-97.
18. Haagsma, C.J., Blom, H.J., van Riel, P.L., van't Hof, M.A., Giesendorf, B.A., van Oppenraaij-Emmerzaal, D. & van de Putte, L.B. (1991) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 58, 79-84.
19. Hattori, H., Matsuzaki, A., Suminoe, A., Ihara, K., Nagatoshi, Y., Sakata, N., Kawa, K., Okamura, J. & Hara, T. (2002) Polymorphisms of growth factor-beta1 and transforming growth factor-beta 1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplantation, 30, 665-671.
20. Hoffmann, S.C., Stanley, E.M., Darrin, C.E., Craighead, N., DiMercurio, B.S., Koziol, D.E., Harlan, D.M., Kirk, A.D. & Blair, P.J. (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation, 72, 1444-1450.
21. Holler, E., Roncarolo, M.-G., Hintermeier-Knabe, R., Eissner, G., Ertl, B., Schulz, U., Knabe, H., Kolb, H.-J., Andreesen, R. & Wilmanns, W. (2000) Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplantation, 25, 237-241.
22. Holler, E., Rogler, G. & Herfarth, H. (2004) Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood, 104, 889-894.
23. Ishikawa, Y., Kashiwase, K., Akaza, K., Morishima, Y., Inoko, H., Sasazuki, T., Kodera, Y. & Juji, T. (2002) Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation. Bone Marrow Transplantation, 29, 569-575.
24. Keen, L.J., DeFor, T.E., Bidwell, J.L., Davies, S.M., Bradley, B.A. & Hows, J.M. (2004) Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood, 103, 3599-3602.
25. Klein, C.A., Wilke, M., Pool, J., Vermeulen, C., Blokland, E., Burghart, E., Krostina, S., Wendler, N., Passlick, B., Riethmüeller, G. & Goulmy, E. (2002) The hematopoietic system-specific minor histocompatibility antigen HA-1 shows aberrant expression in epithelial cancer cells. Journal of Experimental Medicine, 196, 359-368.
26. Kögler, G., Middleton, P.G., Wilke, M., Rocha, V., Esendam, B., Enczmann, J., Wernet, P., Gluckman, E., Querol, S., Lecchi, L., Goulmy, E. & Dickinson, A.M. (2002) Recipient cytokine genotypes for TNF-a and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GvHD in unrelated cord blood transplantation. Transplantation, 74, 1167-1175.
27. Leather, H.L. (2004) Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplantation, 33, 137-152.
28. Leffell, M.S., Vogelsang, G.B., Lucas, P.B., Delaney, N.L. & Zachary, A.A. (2001) Association between TGF-beta and severe GvHD in allogeneic bone marrow transplantation. Transplantation Proceedings, 33, 485-486.
29. Lin, M.T., Storer, B., Martin, P.J., Tseng, L.H., Gooley, T., Chen, P.J. & Hansen, J.A. (2003) Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. The New England Journal of Medicine, 349, 2201-2210.
30. Lorenz, E., Schwartz, D.A., Martin, P.J., Gooley, T., Lin, M.T., Chien, J.W., Hansen, J.A. & Clark, J.G. (2001) Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 7, 384-387.
31. MacMillan, M.L., Radloff, G.A., DeFor, T.E., Weisdorf, D.J. & Davies, S.M. (2003a) Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation. British Journal of Haematology, 121, 597-604.
32. MacMillan, M.L., Radloff, G.A., Kiffmeyer, W.R., DeFor, T.E., Weisdorf, D.J., Davies, S.M. (2003b) High-producer Interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation. Transplantation, 76, 1758-1762.
33. Marijt, W.A., Heemskerk, M.H., Kloosterboer, F.M., Goulmy, E., Kester, M.G., van der Hoorn, M.A., van Luxemburg-Heys, S.A., Hoogeboom, M., Mutis, T., Drijfhout, J.W., van Rood, J.J., Willemze, R. & Falkenburg, J.H. (2003) Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remisions of relapsed leukemia. Proceedings of the National Academy of Sciences of the United States of America, 100, 2742-2747.
34. Meadows, L., Wang, W., den Haan, J.M., Blokland, E., Reinhardus, C, Drijfhout, J.W., Shabanowitz, J., Pierce, R., Agulnik, A.I., Bishop, C.E., Hunt, D.F. & Goulmy, E. (1997) The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity, 6, 273-281.
35. Middleton, P.G., Taylor, P.R.A., Jackson, G., Proctor, S.J. & Dickinson, A.M. (1998) Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood, 92, 3943-3948.
36. Middleton, P.G., Cullup, H., Dickinson, A.M., Norden, J., Jackson, G.H., Taylor, P.R.A. & Cavet, J. (2002) Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. Bone Marrow Transplantation, 30, 223-228.
37. Middleton, P.G., Cullup, H., Cavet, J., Jackson, G.H., Taylor, P.R.A. & Dickinson, A.M. (2003) Estrogen receptor alpha gene polymorphism associates with occurrence of graft versus host disease and reduced survival in HLA identical sib-allo BMT. Bone Marrow Transplantation, 32, 41-47.
38. Miklos, D.B., Kim, H.T., Zorn, E., Hochberg, E.P., Guo, L., Mattes-Ritz, A., Viatte, S., Soiffer, R.J., Antin, J.H. & Ritz, J. (2004) Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood, 103, 353-359.
39. Mocellin, S., Panelli, M.C., Wang, E., Nagorsen, D. & Marincola, F.C. (2003) The dual role of IL-10. Trends in Immunology, 24, 36-43.
40. Mullighan, C.G., Heatley, S., Doherty, K., Szabo, F., Grigg, A., Hughes, T.P., Schwerer, A.P., Szer, J., Tait, B.D., Bik To, L. & Bardy, P.G. (2002) Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood, 99, 3524-3529.
41. Mutis, T., Verdijk, R., Schrama, E., Esendam, B., Brand, A. & Goulmy, E. (1999) Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood, 93, 2336-2341.
42. Randolph, S.S., Gooley, T.A., Warren, E.H., Appelbaum, F.R. & Riddell, S.R. (2004) Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood, 103, 347-352.
43. Reddy, P. & Ferrara, J.L.M. (2003) Immunobiology of acute graft-versus-host disease. Blood Reviews, 17, 187-194.
44. Rocha, V., Franco, R.F., Porcher, R., Bittencourt, H., Silva, Jr, W.A., Latouche, A., Devergie, A., Esperou, H., Ribaud, P., Socié, G., Zago, M.A. & Gluckman, E. (2002) Host defence and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplant. Blood, 100, 3908-3918.
45. Rocha, V., Porcher, R., Filion, A., Bittencourt, H., Zanette, D., Vilela, G., Silva, Jr, W.A., Devergie, A., Esperou, H., Ribaud, P., Socié, G., Gluckman, E. & Zago, M.A. (2003) Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation. Blood, 102, 24a (abstract 848).
46. Socié, G., Loiseau, P., Tamouza, R., Janin, A., Busson, M., Gluckman, E. & Charron, D. (2001) Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation, 72, 699-705.
47. Spink, CF., Keen, L.J., Middleton, P.G. & Bidwell, J.L. (2004) Discrimination of suballeles present at the TNFd microsatellite locus using induced heteroduplex analysis. Genes and Immunity, 5, 76-79.
48. Stark, G.L., Dickinson, A.M., Jackson, G.H., Taylor, P.R., Proctor, S.J. & Middleton, P.G. (2003) Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation. Transplantation, 76, 1742-1749.
49. Turner, D.M., Grant, S.C.D., Lamb, W.R., Brenchley, P.E.C., Dyer, P.A., Sinnott, P.J. & Hutchinson, I.V. (1995) A genetic marker of high TNFalpha production in heart transplant recipients. Transplantation, 60, 1113-1117.
50. Turner, D., Grant, S.C., Yonan, N., Sheldon, S., Dyer, P.A., Sinnott, P.J. & Hutchinson, I.V. (1997a) Cytokine gene polymorphism and heart transplant rejection. Transplantation, 64, 776-779.
51. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J. & Hutchinson, I.V. (1997b) An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1-8.
52. Ulrich, C.M., Yasui, Y., Storb, R., Schubert, M.M., Wagner, J.L., Bigler, J., Ariail, K.S., Keener, C.L., Li, S., Liu, H., Farin, F.M. & Potter, J.D. (2001) Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood, 98, 231-234.
53. Vogt, M.H., van den Muijsenberg, J.W., Goulmy, E., Spierings, E., Kluck, P., Kester, M.G., van Soest, R.A., Drijfhout, J.W., Willemze, R. & Falkenburg, J.H. (2002) The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood, 99, 3027-3032.
54. Wang, W., Meadows, L.R., den Haan, J., Sherman, N.E., Chen, Y., Blokland, E., Shabanowitz, J., Agulnik, A.I., Bishop, C.E., Hunt, D., Goulmy, E. & Engelhard, V.H. (1995) The human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein. Science, 269, 1588-1590.
55. Zino, E., Frumento, G., Marktel, S., Sormani, M.P., Ficara, F., Di Terlizzi, S., Parodi, A.M., Sergeant, R., Martinetti, M., Bontadini, A., Bonifazi, F., Lisini, D., Mazzi, B., Rossini, S., Servida, P., Ciceri, F., Bonini, C, Lanino, E., Bandini, G., Locatelli, F., Apperley, J., Bacigalupo, A., Ferrara, G.B., Bordignon, C. & Fleischhauer, K. (2004) A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood, 103, 1417-1424.